TP53 and cancer: We therefore speculated SH3BGRL expression would be correlated to survival, however, in contrast to what we predicted, a better survival of patients with high SH3BGRL expression in all cancers was seen (Supplementary Fig. 3C), which was independent of p53 mutation status (Supplementary Fig. 3D).